FDA Orange Book · active-ingredient family
Sulfacetamide sodium
Sulfacetamide sodium is approved as 2 brand and 28 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:KLARON · NDA 019931
2
Brand (NDA)
28
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · lotion, ointment, solution/drops
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| KLARONRLD | BAUSCH | NDA 019931 | AB | Dec 23, 1996 | |
| SODIUM SULAMYDRLD×3 | SCHERING | NDA 005963 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (28)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SULFACETAMIDE SODIUM | SUN PHARMA CANADA | ANDA 078668 | — | May 20, 2009 | |
| SULFACETAMIDE SODIUM | PADAGIS US | ANDA 078649 | AB | Mar 23, 2009 | |
| SULFACETAMIDE SODIUM | FOUGERA PHARMS | ANDA 077015 | AB | Nov 17, 2006 | |
| SULFACETAMIDE SODIUM | EPIC PHARMA LLC | ANDA 040216 | — | May 25, 1999 | |
| SULFACETAMIDE SODIUM | PHARMOBEDIENT | ANDA 040215 | — | May 25, 1999 | |
| SULF-15 | NOVARTIS | ANDA 089047 | — | Oct 31, 1995 | |
| SULFACETAMIDE SODIUM | BAUSCH AND LOMB | ANDA 040066 | AT | Dec 28, 1994 | |
| SULFACETAMIDE SODIUM | CHARTWELL RX | ANDA 089560 | AT | Oct 18, 1988 | |
| SULFACETAMIDE SODIUM | ALCON PHARMS LTD | ANDA 089068 | — | May 05, 1987 | |
| SULFACETAMIDE SODIUM | PHARMAFAIR | ANDA 088947 | — | May 17, 1985 | |
| SULFAIR FORTE | PHARMAFAIR | ANDA 088385 | — | Oct 13, 1983 | |
| SULFAIR-15 | PHARMAFAIR | ANDA 088186 | — | May 25, 1983 | |
| SULTEN-10 | BAUSCH AND LOMB | ANDA 087818 | — | Feb 03, 1983 | |
| SULFAIR 10 | PHARMAFAIR | ANDA 088000 | — | Dec 22, 1982 | |
| SULFAIR 10 | PHARMAFAIR | ANDA 087949 | — | Dec 13, 1982 | |
| BLEPH-10 | ALLERGAN | ANDA 084015 | — | Approved Prior to Jan 1, 1982 | |
| CETAMIDE | ALCON | ANDA 080021 | — | Approved Prior to Jan 1, 1982 | |
| SULFACETAMIDE SODIUM | PADAGIS US | ANDA 080029 | — | Approved Prior to Jan 1, 1982 | |
| BLEPH-10RLD×2 | ALLERGAN | ANDA 080028 | — | Approved Prior to Jan 1, 1982 | |
| ISOPTO CETAMIDE | ALCON | ANDA 080020 | — | Approved Prior to Jan 1, 1982 | |
| OCUSULF-10×2 | MIZA PHARMS USA | ANDA 080660 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM SULFACETAMIDE×3 | EPIC PHARMA LLC | ANDA 083021 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM SULFACETAMIDE | SOLA BARNES HIND | ANDA 084143 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM SULFACETAMIDE | SOLA BARNES HIND | ANDA 084145 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM SULFACETAMIDE | SOLA BARNES HIND | ANDA 084146 | — | Approved Prior to Jan 1, 1982 | |
| SODIUM SULFACETAMIDE | SOLA BARNES HIND | ANDA 084147 | — | Approved Prior to Jan 1, 1982 | |
| SULF-10 | NOVARTIS | ANDA 080025 | — | Approved Prior to Jan 1, 1982 | |
| SULFACEL-15 | OPTOPICS | ANDA 080024 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Sulfacetamide sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

